The Eli and Edythe Broad Foundation created the Broad Medical Research Program (BMRP) for Inflammatory Bowel Disease (IBD) Grants in 2001, and it merged with the Crohn’s & Colitis Foundation of America in 2014 to form the Broad Medical Research Program at CCFA (BMRP-CCFA).
IBD refers to two chronic inflammatory gastrointestinal disorders: Crohn's disease and ulcerative colitis. Although numerous scientific advances have been made in understanding and treating IBD, the precise cause, successful treatment and prevention of IBD remain unknown.
The BMRP-CCFA provides 40 percent of all private funding for IBD research in the United States. Our approach is different than many traditional scientific and medical funding organizations. We fund early stage investigation – with the goal that innovative ideas need financial support for early testing to ultimately lead to effective treatment, diagnosis and prevention of IBD.
The BMRP-CCFA provides rapid funding to investigators working in non-profit organizations worldwide for up to two years for basic or clinical IBD research projects that:
- Are innovative
- Are in the early stages of exploration
- Will improve the diagnosis, therapy or prevention of IBD in the near future; and
- Will lead to longer-term funding by more traditional granting agencies
The BMRP-CCFA provides funding to generate pilot research data, rather than serving as the final grant source for a research project. Grantees are encouraged to generate sufficient preliminary data in the first year in order to compete successfully for continuation funding from us and/or other sources.
A grantee may receive second-year funding from the BMRP-CCFA if the researcher demonstrates maximal progress in the first year of the grant, validates the original research premise and demonstrates a clear need for additional preliminary data.
Because we believe that great ideas could come from non-traditional sources, we encourage basic and clinical investigators and scientists not currently working in IBD and interdisciplinary teams to apply.